These percentages highlighted the unmet needs in managing T2DM patients in Egypt, which could be attributed to the delay of insulin therapy, overuse of human insulin, overuse of vials, lack of diabetes education, and lack of healthcare support. This evidence concerns the gene INS and diabetes mellitus.